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Abstract
Background: Chronic, mostly musculoskeletal pain is common among older adults. Little is known about the prognosis
of chronic pain and the neuropathic pain qualities in older adults. We studied a cohort of community-dwelling
older adults, clinically assessed their pain states, classified their type of pain (nociceptive, neuropathic or combined) and
followed them up for a year.
Methods: At baseline, a geriatrician clinically examined all study patients and classified their type of pain in collaboration
with a pain specialist. Pain, quality of life and mental health were measured by questionnaires (BPI, GDS-15, BAI and SF-36)
and reassessed after 1 year.
Results: Despite chronic pain, all patients from the baseline cohort continued to live independently at 1 year. A total of
92 of 106 (87%) patients returned the follow-up questionnaire. Nociceptive pain on its own was present in 48 patients,
whereas 44 patients also had neuropathic pain. Most patients (96%) had several pain states at baseline, and 13 patients
reported a new pain state at follow-up. On average, there were no significant changes in the pain intensity, pain
interference, mood or quality of life in either group between baseline and follow-up. Changes in pain were observed at
the individual level, and both intensity and interference of pain at the follow-up had a negative correlation with the
baseline value.
Conclusions: On average, chronic pain was persistent in our patients, but they were able to live independently despite
their pain. At the individual level, both relief and exacerbation of pain were observed, supporting the notion that pain
is not inevitable and unremitting among older adults.
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Background
It has been estimated that 20% of the European popula-
tion suffers from chronic pain [1], affecting most often
the musculoskeletal system [2]. Chronic pain impairs ac-
tivities of daily living and mobility, and may predict the
progression of disability in home-dwelling older persons
[3]. Chronic pain can be classified according to its
pathophysiology into nociceptive pain, neuropathic pain,
and pain without a known somatic background [4].
Nociception is known to change with advancing age
[5]. The oldest old adapt to living and coping with
chronic pain [6]. In population-based studies, neuro-
pathic pain has been more severe than other types of
pain [7, 8]. Depression and anxiety appear to be more
common in patients with neuropathic pain compared to
those without [9]. However, it is not known whether this
is true of older people. To date, there are no studies
comparing cohorts of older adults with different chronic
pain types in longitudinal settings, while follow-up stud-
ies on chronic pain are scarce [10, 11].
Our aim was to study and follow up a cohort of
home-dwelling older adults with chronic pain. We have
shown in our previous study that patients with neu-
ropathic pain have more severe pain and greater disabil-
ity than other patients with chronic pain [12]. As
neuropathic pain is known to be difficult to treat and
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intractable in many cases, we presumed that those with
neuropathic pain might have less favorable prognosis of
their pain in follow-up. In this study we report the re-
sults on pain, mental health and quality of life at a 1-
year follow-up by comparing patients with and without
neuropathic pain.
Methods
The municipality of Kirkkonummi (population 37,600
inhabitants in 2012) organized preventive home visits in
the period 2009–2013 for older adults aged 75, 80 and
85 years who lived independently at home. Adults in the
target age-group were given an opportunity for a home
visit by a nurse. Among other issues, the presence of
chronic (duration >3 months) pain was inquired using a
one-sheet questionnaire. Those having pain with an
average daily intensity of ≥4 on a numeric rating scale
(NRS) during the previous week or with at least moder-
ate interference in daily life were offered a consultation
with a geriatrician (SR-P). The exclusion criteria were
impaired cognitive function (MMSE <23) or impaired
communication skills (aphasia or insufficient ability to
speak Finnish or Swedish).
During the consultation visit, the study nurse intro-
duced the procedure to the patient and handed four
questionnaires to them. To cover the burden of pain, we
chose questionnaires for intensity and interference of
pain, depression, anxiety and quality of life, using the Se-
verity and Intensity subscales of the Brief Pain Inventory
(BPI) [13], the Geriatric Depression Scale (GDS-15) [14],
the Beck Anxiety Inventory (BAI) [15], and the Medical
Outcomes Survey Short Form (SF-36) [16], which are
validated and widely used instruments in clinical studies.
BPI
The BPI is a patient-completed numeric rating scale that
assesses the severity of pain (Severity scale) and its im-
pact on daily functioning (Interference scale). The Pain
Interference Scale assesses the degree to which pain in-
terferes with seven daily activities (general activity,
mood, normal work, walking, relations with others,
sleep, and enjoyment of life). The ratings are measured
using 11-point numeric rating scales ranging from 0
(does not interfere) to 10 (completely interferes). The
mean of these seven ratings is used to indicate the pa-
tient’s overall level of pain interference.
GDS-15
The GDS-15 was designed as a self- or interviewer-
administered screening instrument and consists of ques-
tions addressing various depressive symptoms and is of
particular value for use with older patients since it has a
simple yes/no format and does not rely on somatic
symptoms that may be part of the normal ageing process
or an associated physical illness.
BAI
The BAI is a 21-item screening instrument designed as
a general measure of anxiety and to differentiate symp-
toms of anxiety from symptoms of depression. The
items are answered on a 4-point Likert-type scale ran-
ging from 0 (not at all) to 3 (severe, I could barely
stand it). The responses are summed to provide a score
ranging from 0 to 63, with higher scores indicative of
higher levels of anxiety.
SF-36
The SF-36 is a short questionnaire with 36 items which
measure eight multi-item variables: physical functioning
(10 items), social functioning (two items), role limita-
tions due to physical problems (four items), role limita-
tions due to emotional problems (three items), mental
health (five items), energy and vitality (four items), pain
(two items), and general perception of health (five
items). There is a further unscaled single item on
changes in respondents’ health over the past year [16].
After the patient had filled in the questionnaires the
geriatrician examined the patients with the aim of diag-
nosing the etiology of the pain state(s) and the type(s) of
pain (nociceptive, neuropathic or combined). If clinically
indicated, the geriatrician had an opportunity to refer
the patients for laboratory or imaging investigations or
for a consultation with another specialist (e.g., neuro-
logist or orthopedic surgeon etc.). As appropriate, the
geriatrician modified the pain treatment (e.g., recom-
mendation of dose escalation or trial of another drug for
alleviating pain). The GPs then followed up the modified
treatment plans.
A follow-up questionnaire was sent to the patients
1 year after the visit to the geriatrician. It included ques-
tions on current pain medication and possible new pain
states, and the severity and intensity subscales of the
BPI, GDS-15, BAI and SF-36. Information about the
diagnostic procedures and treatment of pain during the
follow-up period were checked and collected from the
files of each patient by the geriatrician (SR-P).
Statistical methods
Results are presented using means, standard deviations
and frequency distributions. Statistical significance be-
tween groups was tested by the t-test, Mann-Whitney
test or chi-square test. In the case of a violation of the
assumptions (e.g. non-normality), a permutation-type
test was used. The differences between groups in
changes over the 1-year period were compared using a
bootstrap-type ANCOVA with the baseline measure-
ment as a covariate. Correlation coefficients were
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calculated by the Pearson method. The normality of the
variables was tested using the Shapiro-Wilk W test. The
statistical package used was Stata 14.0, StataCorp LP
(College Station, TX, USA).
Ethics approval
The study protocol was approved by the Ethics Commit-
tee of the Helsinki University Central Hospital (permis-
sion 128/13/03/00/09), and written informed consent
was obtained from all participants.
Results
Altogether 92 (26 men, 28% and 66 women, 72%) of 106
patients from the original cohort replied to the follow-
up postal survey, representing 87% of the baseline co-
hort. According to patient files, all patients from the
original cohort continued to live independently at home.
None of the patients in the baseline cohort had died,
and the reasons for non-response to the follow-up ques-
tionnaire remain unknown.
Four patients (4%) had only one pain state and 88
(96%) patients had two or more different pain states.
Nociceptive pain on its own was present in 48 (52%) pa-
tients, whereas 44 (48%) patients also had neuropathic
pain. None of our patients had neuropathic pain alone.
The causes of nociceptive pain were spine disorders
(n = 55, 60%), osteoarthritis of limb joints (n = 38, 41%),
soft tissue disorders (n = 28, 30%, with shoulder pain in
16), sequelae of injuries (n = 9, 10%), inflammatory poly-
arthropaties (n = 5, 5%), visceral pain (n = 5, 5%) and
primary headache (n = 2, 2%). Neuropathic pain was due
to degenerative disease of the spine causing radiculopa-
thy (n = 25, 59% of the cases of neuropathic pain), per-
ipheral nerve trauma (n = 7, 16%), peripheral nerve
entrapment (n = 4, 9%), painful polyneuropathy (n = 4,
9%), postherpetic neuralgia (n = 3, 7%) and central post-
stroke pain (n = 1, 2%).
The baseline characteristics of patients with and with-
out neuropathic pain are presented in Table 1. The only
significant difference between the groups was for gender
(neuropathic pain was less common in women). Mean
(SD) intensity of pain was 4.1 (2.0) in patients without
neuropathic pain and 5.1 (1.8) in patients with neuro-
pathic pain (p = 0.003, adjusted for age and gender).
Mean (SD) interference of pain was 3.4 (2.4) in patients
without neuropathic pain and 4.5 (2.3) in patients with
neuropathic pain (p = 0.007, adjusted for age and gender).
Median (IQR) follow-up time was 12 [8, 15] months in
patients without neuropathic pain and 12 [8, 12] months
in those with neuropathic pain.
The treatment of patients with and without neuro-
pathic pain is presented in Table 2. Compared to base-
line, medication was changed at the follow-up in 30
cases: a new drug was prescribed for 22 patients, and
Table 1 Baseline characteristics of patients without neuropathic






Number of women, (%) 41 (85) 25 (57) 0.002
Age group, years, N (%) 0.87
75 30 (62) 29 (66)
80 12 (25) 11 (25)
85 6 (13) 4 (9)
Living alone, N (%) 25 (53) 18 (41) 0.24
Duration of pain, years, (%) 0.72
< 1 8 (17) 8 (18)
1–2 15 (31) 10 (23)
≥ 3 25 (52) 26 (59)
MMSE, mean (SD) 28 (2) 27 (2) 0.44
Subjective health, N (%) 0.97
Good 17 (37) 16 (36)
Satisfactory 21 (46) 21 (48)
Insufficient 8 (17) 7 (16)
Subjective moving capability, n (%) 0.76
Good 16 (33) 15 (34)
Satisfactory 18 (38) 19 (43)
Insufficient 14 (29) 10 (23)
Comorbidities
Cardiovascular diseases 35 (73) 29 (66) 0.47
Musculoskeletal diseases 31 (65) 21 (48) 0.10
Endocrine diseases 22 (46) 18 (41) 0.63
Respiratory diseases 13 (27) 8 (18) 0.31
Neoplasms 6 (13) 4 (9) 0.60
Psychiatric diseases 2 (4) 0 (0) 0.49
Nervous system diseases 1 (2) 3 (7) 0.35
BAI, mean (SD) 12.6 (8.1) 13.5 (11.6) 0.68
GDS-15, mean (SD) 3.04 (2.50) 3.84 (3.02) 0.18
SF-36, mean (SD)
Physical Component Summary 34 (12) 33 (11) 0.63
Mental Component Summary 53 (10) 52 (11) 0.57
Pain medication, N (%) 36 (75) 36 (82) 0.43
Paracetamol 29 (60) 24 (55) 0.57
NSAID (peroral) 14 (29) 19 (43) 0.16
NSAID (topical) 8 (17) 2 (5) 0.093
Mild opioid 5 (10) 7 (16) 0.54
Neuropathic pain druga 3 (6) 4 (9) 0.71
NEP-, without neuropathic pain, NEP+, with neuropathic pain
BAI Beck Anxiety Inventory; GDS-15 Geriatric Depression Scale, SF-36 Medical
Outcomes Survey Short Form
*Adjusted age and gender
aAntidepressant drug, antiepileptic drug or topical lidocaine for pain
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the dose was modified for 8 patients. Physiotherapy was
recommended for 27 patients and assistive devices (orth-
osis, orthotic insoles, orthotic vest or collar) were rec-
ommended for 8 patients. Twelve patients were referred
to a specialist consultation. There were no significant
differences between the groups regarding treatments.
Nine patients underwent surgery due to chronic pain
(total hip replacement for 5 patients, total knee replace-
ment for 1, lumbar decompression for 2 and nerve en-
trapment decompression to 1).
At the follow-up, 13 patients reported experiencing a
new type of pain. The diagnosis was osteoarthritis of
limb joints in 5 patients, visceral pain in 2, painful poly-
neuropathy in 2, bone fracture in 2, spinal disorder in 1,
and recent herpes zoster in 1.
During the follow-up, there were no significant
changes in the pain intensity in either group. The
change in the intensity of pain (NRS 0–10) in those
without neuropathic pain was −0.01 (95% CI: -0.49 to
0.48), p = 0.97 and in those with neuropathic pain −0.11
(95% CI: -0.79 to 0.58), p = 0.65. Differences in the
changes did not differ significantly between the groups
(p = 0.22, adjusted at baseline). The change in the inter-
ference from pain (NRS 0–10) in those without neuro-
pathic pain was 0.76 (95% CI: 0.18 to 1.34), p = 0.011
and in those with neuropathic pain 0.09 (95% CI: -0.54
to 0.73), p = 0.77. The change in the interference from
pain did not significantly differ between the groups
(p = 0.59, adjusted at baseline). The relationship of pain
at baseline and the change during follow-up regarding
the intensity and interference is presented in Fig. 1. Both
intensity and interference had a negative correlation
with the baseline value.
Change in depression, anxiety and quality of life dur-
ing the follow-up is presented in Table 3. No significant
change was observed within or between the groups.
Discussion
Chronic pain among older adults remained mostly the
same at the group level in our 1-year follow-up study.
This is in line with a previous longitudinal study in
which three-quarters of community-dwelling older
adults with pain at baseline had similar pain at 1- and 2-
year follow-ups [10]. However, at the individual level we
observed both relief and worsening of pain. There was a
regression towards the mean in both pain intensity and
interference. The variables that were extreme in the first
measurement tended to be closer to the average in the
second measurement. In both nociceptive and neuro-
pathic pain groups, patients with more severe pain re-
ported a decrease and those with milder pain reported
an increase in pain. Musculoskeletal pain was similarly
reported to fluctuate in the study by Karttunen and col-
leagues [10].
In a large community-based cohort study from the
USA that included adults aged 65 or older, musculoskel-
etal pain was assessed annually for 6 years. One-third of
adults reported pain intermittently and another third for
three or more consecutive years. The authors concluded
that their findings refuted the notion that pain is inevit-
able, unremitting or a progressive consequence of aging
[11]. This is in line with our observation that some
Table 2 New treatments provided to patients without neuropathic
pain and with neuropathic pain during the follow-up time
Variable NEP- (N = 48)
N (%)
NEP+ (N = 44)
N (%)
P-value
Change in medication 12 (25) 18 (41) 0.10
Assistive devices 7 (15) 1 (2) 0.061
Physiotherapy 14 (29) 13 (30) 0.97
Diagnostic procedures 7 (15) 5 (11) 0.65
Fig. 1 Relationship of pain at baseline and change during follow-up regarding intensity and interference. Significant correlations were between
baseline and change of pain intensity and interference. ● = with neuropathic pain, o = without neuropathic pain
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patients experience pain relief at follow-up but new pain
conditions appear to the others.
None of our patients had neuropathic pain alone. Two
leading causes for neuropathic pain (comprising three
quarters of neuropathic pain cases in our cohort) were
spinal pain and posttraumatic pain, which are typical
examples of mixed pain states (combination of nociceptive
and neuropathic pain). In addition, osteoatrhrosis and
other degenerative musculoskeletal pain conditions caus-
ing nociceptive pain are very common in older adults,
who may have also a separate neuropathic pain state.
In our cohort, patients with a neuropathic pain had
higher pain intensity and interference compared with
those without neuropathic pain [12]. This is in accord-
ance with previous large population-based studies [7–9].
Reasons for this may include the refractory nature of
neuropathic pain with regard to pharmacotherapy [17]
and the unpredictable character of neuropathic pain; ex-
acerbations may appear without any identifiable provo-
king factors, whereas nociceptive pain has clearer
provoking factors (e.g., it is possible to control the pain
of knee osteoarthritis by restricting activity) [18].
In spite of chronic pain, our patients did not have major
mental health problems, and their anxiety and depression
scores remained low. This may reflect their ability to cope
with pain and to adapt to restrictions caused by conditions
causing pain [6, 18]. Most of the patients in both groups
had experienced pain over 3 years which also may have
significant impact of coping with pain.
Our study was not designed to assess the effects of
different pain management options. The GPs provided
management to the patients according to their own judg-
ment. The decisions were based on clinical practice,
guidelines and individual consideration of the usefulness
of treatments. Management of our patients included
modification of pharmacotherapy, physiotherapy, assistive
devices, and referral to surgery or specialist consultation.
The strength of our study is that our cohort consisted
of a population-driven sample of home-dwelling older
adults that were clinically studied in detail at baseline. A
pain specialist (MH) was consulted to make sure the
pain states were correctly classified. The follow-up was
performed with mailed questionnaires after approxi-
mately 1 year.
The limitations of the study include the selected co-
hort group instead of a population-based group of sub-
jects and the limited size of the study group, which
diminish the possibility to generalize our results. Other
limitations consist of the relatively short follow-up time
of chronic pain and the follow-up using only question-
naires; control visits might have provided more detailed
information. We recommend that researchers aim at
population-based studies with long-term follow-up and
face-to-face control visits in the future.
Conclusions
We conclude that on average, chronic pain was persist-
ent but fluctuating in our patients at the 1-year follow-
up and no significant changes were noticed between
neuropathic and non-neuropathic pain groups. At the
individual level, both relief and exacerbation of pain was
observed, supporting the notion that pain is not inevi-
table or unremitting among older adults. The mental
wellbeing of the patients remained good, and they were
able to continue living independently despite their pain.
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Table 3 Change during follow-up in depressive symptoms,
anxiety and quality of life
Variable NEP- (N = 48)
Change (95% CI)
NEP+ (N = 44)
Change (95% CI)
P-value*
GDS-15 0.5 (−0.3 to 1.3) 0.2 (−0.5 to 0.9) 0.93




−2 (−4 to 1) −2 (−4 to 1) 0.75
Mental Component
Summary
−3 (−6 to 1) −2 (−4 to 1) 0.78
NEP-, without neuropathic pain, NEP+, with neuropathic pain
BAI Beck Anxiety Inventory, GDS-15 Geriatric Depression Scale, SF-36 Medical
Outcomes Survey Short Form
*Baseline adjusted
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